Target intelligence / Profile preview

Small ruminant morbillivirus (SRMV)

Target
SRMV
Molecular classification
Virus, Morbillivirus, Paramyxoviridae
01

Overview

Small ruminant morbillivirus (SRMV), formerly known as Peste des petits ruminants virus (PPRV), is a highly contagious viral pathogen belonging to the genus Morbillivirus within the family Paramyxoviridae [1.1.1, 1.3.1]. It is the causative agent of Peste des Petits Ruminants (PPR), a severe and often fatal disease primarily affecting sheep and goats, characterized by high fever, oculonasal discharge, necrotizing stomatitis, and pneumonia [1.2.1, 1.2.5]. The virus possesses a non-segmented, negative-sense RNA genome encoding six structural proteins (N, P, M, F, H, L) and two non-structural proteins (C, V) [1.5.4]. Viral entry into host cells is mediated by the binding of the hemagglutinin (H) protein to receptors such as Signaling Lymphocytic Activation Molecule (SLAM/CD150) and Nectin-4 [1.2.1, 1.5.3]. Therapeutic strategies focus on vaccination using live-attenuated strains like Nigeria 75/1 and Sungri/96 to induce lifelong immunity, while antiviral research explores inhibitors of the viral RNA-dependent RNA polymerase, such as ribavirin [1.4.1, 1.5.3]. SRMV is a major target for global eradication efforts led by the Food and Agriculture Organization (FAO) and the World Organisation for Animal Health (WOAH), aiming for elimination by 2030 [1.3.1, 1.4.2].

Other names
Peste des petits ruminants virusPPRVGoat plague virusOvine rinderpest virusMorbillivirus caprinaeKata virus
02

Mechanism of action

Inhibition of viral RNA-dependent RNA polymerase (RdRp) by ribavirin; induction of protective neutralizing antibodies against viral glycoproteins (H and F) by live-attenuated vaccines.

03

Biological functions

Viral replicationHost cell entryImmune evasionImmunosuppressionCell fusion
04

Disease associations

InfectionPeste des Petits Ruminants
05

Safety considerations

Vaccine thermolabilitySecondary bacterial infectionsHigh mortality in goatsImmunosuppression
06

Interacting drugs

Ribavirin

4 more in the full profile.

07

Biomarkers

Viral RNANucleocapsid (N) proteinHemagglutinin (H) proteinNeutralizing antibodies

Beyond the preview

Go deeper on Small ruminant morbillivirus (SRMV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small ruminant morbillivirus (SRMV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call